Mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction: An experimental and clinical review

ASAIO Journal

Volumn 53, Issue 3, 2007, Pages 278-287

  Garatti, Andrea ^a   Russo, Claudio ^a   Lanfranconi, Marco ^a   Colombo, Tiziano ^a   Bruschi, Giuseppe ^a   Trunfio, Salvatore ^a   Milazzo, Filippo ^a   Catena, Emanuele ^a   Colombo, Paola ^a   Maria, Frigerio ^a   Vitali, Ettore ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; DATA REDUCTION; HEMODYNAMICS; PATIENT TREATMENT;

CARDIOGENIC SHOCK (CS); FIBRINOLYSIS; MYOCARDIAL INFARCTIONS; PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY;

CARDIOLOGY;

ACUTE HEART INFARCTION; ANATOMY; AORTA BALLOON; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL STUDY; COMPARATIVE STUDY; DEMOGRAPHY; EXPERIMENTAL STUDY; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE REPERFUSION; HUMAN; IMPLANT; NONHUMAN; PATHOPHYSIOLOGY; SURGICAL TECHNIQUE; SURVIVAL RATE;

HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC;

EID: 34249059273     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318057fae3     Document Type: Article

References (77)

1. Goldberg RJ, Samad NA, Yarzebski J, et al: Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340: 1162-1168, 1999.
2. Holmes DR Jr, Bates ER, Kleiman NS, et al: Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience: the GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 26: 668-674, 1995.
3. Hochman JS, Sleeper LA, White HD, et al: SHOCK Investigators: should we emergently revascularize occluded coronaries for cardiogenic shock? One-year survival following early revascularization for cardiogenic shock. JAMA 285: 190-192, 2001.
4. Hochman JS, Sleeper LA, Webb JG, et al: Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 341: 625-634, 1999.
5. Webb JG, Sanborn TA, Sleeper LA, et al: SHOCK Investigators: percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J 141: 964-970, 2001.
6. Hochman JS, Buller CE, Sleeper LA, et al: Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol 36: 1063-1070, 2000.
7. Scheidt S, Wilner G, Mueller H, et al: Intra-aortic balloon counterpulsation in cardiogenic shock: report of a co-operative clinical trial. N Engl J Med 288: 979-984, 1973.
8. DeWood MA, Notske RN, Hensley GR, et al: Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 61: 1105-1112, 1980.
9. Pae W, Pierce W: Temporary left ventricular assistance in acute myocardial infarction and cardiogenic shock. Chest 79: 692-695, 1981.
10. Richenbacher WE, Dash H, Bulck MK, Pierce WS: Utilization of left ventricular assistance in patients with acute myocardial infarction and cardiogenic shock. ASAIO J 7: 32-40, 1984.
11. Laschinger JC, Grossi EA, Cunningham JN, et al: Adjunctive left ventricular unloading plays a major role in minimizing myocardial infarct size. J Thorac Cardiovasc Surg 90: 80-85, 1985.
12. Nishi K, Mori F, Miyamoto M, Esato K: Myocardial protection by a left ventricular assist device during reperfusion following acute coronary occlusion. Jpn J Surg 5: 563-569, 1989.
13. Matsumoto N, Mori F, Nishi K, Esato K, Mohri H: The effect of the left ventricular assist device during reperfusion after acute coronary occlusion. Jpn J Surg 20: 300-306, 1990.
14. Smalling RW, Cassidy DB, Merhige M, et al: Improved hemodynacute MIc and left ventricular unloading during acute ischemia using the Hemopump left ventricular assist device compared to intra-aortic balloon counterpulsation. J Am Coll Cardiol 13: 160A, 1989 (abstract).
15. Scholz KH, Hering JP, Schroder T, et al: Protective effects of the Hemopump left ventricular assist device in experimental cardiogenic shock. Eur J Cardiothorac Surg 6: 209-214, 1992.
16. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W: Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 41: 1087-1095, 2003.
17. Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J: Improved regional myocardial blood flow, left ventricular unloading and infarct salvage using an axial-flow, transvalvular left ventricular assist device. Circulation 85: 1152-1159, 1992.
18. Fonger JD, Zhou Y, Matsuura H, Aldea GS, Shemin RJ: Enhanced preservation of acutely ischemic myocardium with transseptal left ventricular assist. Ann Thorac Surg 57: 570-575, 1994.
19. Reesink KD, Dekker AL, VanOmmen V, et al: Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping. Chest 126: 896-902, 2004.
20. Suga II, Hisano R, Hirata S, et al: Mechanism of higher oxygen consumption rate: pressure-loaded vs volume-loaded heart. Am J Physiol 242: II942- 48, 1982.
21. Pedersen TH, Videm V, Svennevig JL, et al: Extracorporeal membrane oxygenation using a centrifugal pump and a Servo regulator to prevent negative inlet pressure. Ann Thorac Surg 63: 1333-1339, 1997.
22. Kawahito K, Murata S, Yasu T, et al: Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol 82: 910-911, 1998.
23. Kawahito K, Murata S, Adachi H, Ino T, Fuse K: Resuscitation and circulatory support using extracorporeal membrane oxygenation for fulminant pulmonary embolism. Artif Organs 24: 427-430, 2000.
24. Kawahito K, Ino T, Adachi H, Ide H, Mizuhara A, Yamaguchi A: Heparin-coated percutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery. ASAIO J 40: 972-976, 1994.
25. Hill JG, Bruhn PS, Cohen SE, et al: Emergent applications of cardiopulmonary support: a multi-institutional experience. Ann Thorac Surg 54: 699-704, 1992.
26. Willms DC, Atkins PJ, Dembitsky WP, Jaski BE, Gocka I: Analysis of clinical trends in a program of emergent ECMO for cardiovascular collapse. ASAIO J 43: 65-68, 1997.
27. Fujimoto K, Kawahito K, Yamaguchi A, et al: Percutaneous extracorporeal life support for treatment of fatal mechanical complications associated with acute myocardial infarction. Artif Organs 25: 1000-1003, 2001.
28. Jaski BE, Lingle RJ, Overlie P, et al: Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse. ASAIO J 45: 615-618, 1999.
29. Schwarz B, Mair P, Margreiter J, et al: Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med 31: 758-764, 2003.
30. Magliato KE, Kleisli T, Soukiasian HJ, et al: Biventricular support in patients with profound cardiogenic shock: a single center experience. ASAIO J 49: 475-479, 2003.
31. Bavaria JE, Furukawa S, Kreiner G, Gupta KB, Streicher J, Edmunds LH: Effect of circulatory assist devices on stunned myocardium. Ann Thorac Surg 49: 123-128, 1990.
32. Ratcliffe MB, Bavaria JE, Wenger RK, Bogen DK, Edmunds LH: Left ventricular mechanics of ejecting, postischemic hearts during left ventricular circulatory assistance. J Thorac Cardiovasc Surg 101: 245-255, 1991.
33. Entwistle JW III, Bolno PB, Holmes E, Samuels LE: Improved survival with ventricular assist device support in cardiogenic shock after myocardial infarction. Heart Surg Forum 6: 316-319, 2003.
34. Samuels LE, Holmes EC, Garwood P, Ferdinand F: Initial experience with the Abiomed AB5000 ventricular assist device system. Ann Thorac Surg 80: 309-312, 2005.
35. Noda H, Takano H, Taenaka Y, Nakatani T, et al: Treatment of acute myocardial infarction with cardiogenic shock using left ventricular assist device. Int J Artif Org 12: 175-179, 1989.
36. Takano H, Nakatani T: Ventricular assist system: experience in Japan with Toyobo pump and Zeon pump. Ann Thorac Surg 61: 317-322, 1996.
37. Thiele H, Sick P, Boudriot E, Diederich KW et al: Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26: 1276-1283, 2005.
38. Ross JJ, Braunwald E, Morrow A: Left heart catheterization by the transseptal route: a description of the technique and complications. Circulation 22: 927-934, 1960.
39. Dennis C, Hall DP, Moreno JR, Senning A: Left atrial cannulation without thoracotomy for total left heart bypass. Acta Chir Scand 123: 267-279, 1962.
40. Thiele H, Lauer B, Hambrecht R, et al: Reversal of cardiogenic shock by percutaneous left-atrial-to-femoral arterial bypass assistance. Circulation 104: 2917-2922, 2001.
41. Giombolini C, Notaristefano S, Santucci S, et al: Percutaneous left ventricular assist device, Tandem Heart, for high-risk percutaneous coronary revascularization: a single centre experience. Acute Cardiac Care 8: 35-40, 2006.
42. Burkhoff D, O'neill W, Brunckhorst C, Letts D, Lasorda D, Cohen HA: Feasibility study of the use of the Tandem Heart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv 68: 211-2177, 2006.
43. Cequier A, Bonan R, Serra A et al: Left-to-right atrial shunting after percutaneous mitral valvuloplasty: incidence and long-term hemodynamic follow-up. Circulation 81: 1190-1197, 1990.
44. Matsuura H, Yang XM, Fonger JD, et al: Percutaneous bidirectional femoral artery cannulation for extended extracorporeal circulatory support. In Chang JB, ed. Modern Vascular Surgery. Berlin: Springer-Verlag; 1994.
45. DeRobertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A: Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transpl 25: 181-186, 2006.
46. Hoshi H, Shinshi T, Takatani S: Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs 30: 324-338, 2006.
47. Santise G, Petrou M, Pepper JR, Dreyfus G, Khaghani A, Birks EJ: Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation. J Heart Lung Transplant 25: 495-498, 2006.
48. Wampler RK, Baker BA, Wright WM: Circulatory support of cardiac interventional procedures with the Hemopump cardiac assist system. Cardiology 84: 194-201, 1993.
49. Wampler RK, Maise JC, Frazier OH, Olsen DB: In vivo evaluation of a peripheral vascular-access axial-flow blood pump. ASAIO Trans 34: 450-455, 1988.
50. Wampler RK, Frazier OH, Lansing AM, et al: Treatment of cardiogenic shock with the Hemopump left ventricular assist device. Ann Thorac Surg 52: 506-513, 1991.
51. Smalling RW, Sweeney M, Lachterman B, Hess MJ, Morris R, et al: Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. J Am Coll Cardiol 23: 637-644, 1994.
52. Garatti A, Colombo T, Russo C, Lanfranconi M, et al: Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant 24: 481-485, 2005.
53. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R: Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77: 1642-1647, 2004.
54. Siegenthaler MP, Brehm K, Strecker T, Hanke T, et al: The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 127: 812-822, 2004.
55. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W: Initial experiences with the Impella device in patients with cardiogenic shock. Thorac Cardio Surg 51: 1-6, 2003.
56. Mueller XM, Boone Y, Augstburger M, Horisberger J, von Segesser LK: Bi-ventricular axial micropump: impact on blood cell integrity. Swiss Surg 7: 213-217, 2001.
57. Hill JD, Farrar DJ, Hershon JJ, et al: Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 314: 625-628, 1986.
58. Moritz A, Wolner E: Circulatory support with shock due to acute myocardial infarction. Ann Thorac Surg 55: 238-244, 1993.
59. Farrar JD, Lawson JH, Litwak P, Cederwall G: Thoratec VAD system as a bridge-to-heart transplantation. J Heart Transplant 9: 415-423, 1990.
60. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH: The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 71: S77-S81, 2001.
61. Cannon CP, Gibson CM, Lambrew CT, et al: Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283: 2941-2947, 2000.
62. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998-3002, 2003.
63. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112: 676-692, 1997.
64. Yamaguchi T, Sawa Y, Masai T, et al: Hepatic sinusoid endothelial dysfunction plays a role in hyperbilirubinemia in patients following implantation of an LVAD. ASAIO J 43: M449-M452, 1997.
65. Hummel M, Czerlinski S, Fiedel N, et al: Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist patients before heart transplantation. Crit Care Med 22: 448-454, 1994.
66. Maybaun S, Epstein S, Beniacute M, Inovitz A, et al: Partial loading of the LV during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity. J Heart Lung Transplant 21: 446-454, 2002.
67. Tuzun E, Eya K, Chee HK, et al: Myocardial hemodynamics, physiology, and perfusion with an axial flow left ventricular assist device in the calf. ASAIO J 50: 47-53, 2004.
68. Merhige ME, Smalling RW, Cassidy D, et al: Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function: reduction of ischemia during coronary occlusion. Circulation 80: 158-166, 1989.
69. Pego-Fernandes PM, Stolf NA, Moreira LF, et al: Influence of biopump with and without intraaortic balloon on the coronary and carotid flow. Ann Thorac Surg 69: 536-540, 2000.
70. Feigl EO, Neat GW, Huang AH: Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. J Mol Cell Cardiol 22: 375-390, 1990.
71. Cao J, Rittgers SE: Particle motion within in vitro models of stenosed internal carotid and left anterior descending coronary arteries. Ann Biomed Eng 26: 190-199, 1998.
72. Xydas S, Rosen RS, Pinney S, et al: Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. J Heart Lung Transplant 24: 1976-1979, 2005.
73. Allen BS, Okamoto F, Buckberg GD, et al: Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion. J Thorac Cardiovasc Surg 92: 605-612, 1986.
74. Nallamothu BK, Bates ER: Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92: 824-826, 2003.
75. Hasdai D, Holmes DR Jr, Califf RM, et al: for the GUSTO-I Investigators: cardiogenic shock complicating acute myocardial infarction: Predictors of death. Am Heart J 138: 21-31, 1999.
76. Zeymer U, Vogt A, Zahn R, et al: Predictors of in-hospital mortality in 1333 patients with myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 25: 322-328, 2004.
77. Dixon SR, Alkafri H, Chacute MI: Clinical predictors of in-hospital death in patients with cardiogenic shock selected to undergo early revascularization. J Am Coll Cardiol 39: 808-811, 2002.